Multilineage Potential of Adult Human Mesenchymal Stem Cells

American Association for the Advancement of Science (AAAS) - Tập 284 Số 5411 - Trang 143-147 - 1999
Mark F. Pittenger1, Alastair M. Mackay1, Stephen C. Beck1, Rama K. Jaiswal1, R. Gordon Douglas1, Joseph D. Mosca1, M Moorman1, Donald W. Simonetti1, Stewart Craig1, Daniel R. Marshak2,1
1Osiris Therapeutics, 2001 Aliceanna Street, Baltimore, MD 21231–3043, USA.
2Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA

Tóm tắt

Human mesenchymal stem cells are thought to be multipotent cells, which are present in adult marrow, that can replicate as undifferentiated cells and that have the potential to differentiate to lineages of mesenchymal tissues, including bone, cartilage, fat, tendon, muscle, and marrow stroma. Cells that have the characteristics of human mesenchymal stem cells were isolated from marrow aspirates of volunteer donors. These cells displayed a stable phenotype and remained as a monolayer in vitro. These adult stem cells could be induced to differentiate exclusively into the adipocytic, chondrocytic, or osteocytic lineages. Individual stem cells were identified that, when expanded to colonies, retained their multilineage potential.

Từ khóa


Tài liệu tham khảo

10.1126/science.282.5391.1145

Shamlott M. J., et al., Proc. Natl. Acad. Sci. U.S.A. 95, 13726 (1998).

Till J. E., McCulloch E. A., Radiat. Res. 14, 213 (1961);

; B. I. Lord in Stem Cells C. S. Potten Ed. (Academic Press New York 1996) pp. 401–422;

Civin C. I., et al., J. Immunol. 133, 157 (1984) .

Kuznetsov S. A., et al., J. Bone Miner. Res. 12, 1335 (1997);

10.1126/science.276.5309.71

Pereira R. F., et al., Proc. Natl. Acad. Sci. U.S.A. 92, 4857 (1995);

Caplan A. I., J. Orthop. Res. 9, 641 (1991);

Friedenstein A. J., Int. Rev. Cytol. 47, 327 (1976);

; M. Owen and A. J. Friedenstein in Cell and Molecular Biology of Vertebrate Hard Tissues D. Evered and S. Harnett Eds. (Wiley Chichester UK 1988) pp. 42–60.

Friedenstein A. J., Chailakhyan R. K., Gerasimov U. V., Cell Tissue Kinet. 20, 263 (1987);

; B. Ashton et al.. Clin. Orthop. Relat. Res. 151 294 (1980);

Bab I., Howlett C. R., Ashton B. A., Owen M. E., ibid. 187, 243 (1984).

Haynesworth S. E., Goshima J., Goldberg V. M., Caplan A. I., Bone 13, 81 (1992).

Bergman R. J., et al., J. Bone Miner. Res. 11, 568 (1996);

Dennis J. E., Caplan A. I., Connect. Tissue Res. 35, 93 (1996);

Cui Q., Wang G.-J., Balian G., J. Bone Joint Surg. Am. Vol. 79A, 1054 (1997);

Wakitani S., Saito T., Caplan A. I., Muscle Nerve 18, 1417 (1995).

Cassiede P., Dennis J. E., Ma F., Caplan A. I., J. Bone Miner. Res. 11, 1264 (1996);

Grigoriadis A. E., Heersche J. N. M., Aubin J. E., J. Cell Biol. 106, 2139 (1988);

Leboy P. S., Beresford J. N., Devlin C., Owen M. E., J. Cell. Physiol. 146, 370 (1991);

Bellows J. J., Aubin J. E., Dev. Biol. 133, 8 (1989).

Young R. G., et al., J. Orthop. Res. 16, 406 (1998).

Wakitani S., et al., J. Bone Joint Surg. Am. Vol. 76A, 579 (1994);

Johnstone B., Hering T. M., Caplan A. I., Goldberg V. M., Yoo J. U., Exp. Cell Res. 238, 265 (1998).

Kadiyala S., Young R. D., Thiede M. A., Bruder S. P., Cell Transplant. 6, 125 (1997);

Bruder S. P., Kraus K. H., Goldberg V. M., Kadiyala S., J. Bone Joint Surg. Am. Vol. 80A, 985 (1998).

Lennon D. P., et al., In Vitro Cell. Dev. Biol. 32, 602 (1996);

Cheng S.-L., et al., Endocrinology 134, 277 (1994).

Haynesworth S. E., Baber M. A., Caplan A. I., Bone 13, 69 (1992).

Majumdar M. K., et al., J. Cell. Physiol. 176, 57 (1998).

Bruder S. P., et al., Clin. Orthop. Relat. Res. 355S, S247 (1998).

Bucala R., Spiegel L. A., Chesney J., Hogan M., Cerami A., Mol. Med. 1, 71 (1994).

These fibroblasts represented middle passage newborn foreskin fibroblasts (Hs27) which were obtained at passage 14 from the American Type Culture Collection (ATCC) and early passage adult skin fibroblasts (1087Sk) which were obtained at passage 1 from ATCC both with normal karyotype.

M. F. Pittenger U.S. Patent 5 827 740 (1998).

Murine cDNA probes for LPL and PPARγ2 were the gift of J. Gimble (University of Oklahoma School of Medicine Oklahoma City). Polyclonal antibody to aP2 was provided by M. D. Lane (Johns Hopkins University School of Medicine Baltimore MD).

Mackay A. M., Beck S. C., Murphy J. M., Barry F. P., Pittenger M. F., Tissue Eng. 4, 472 (1998);

Yoo J. U., et al., J. Bone Joint Surg. Am. Vol. 80A, 1745 (1998).

Srinivas G. R., Barrach H. J., Chichester C. O., J. Immunol. Methods 159, 53 (1994).

10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F

; N. Jaiswal S. E. Haynesworth A. I. Caplan S. P. Bruder ibid. p. 295; S. P. Bruder et al. J. Bone Miner. Res. 13 655 (1998).

We thank D. Fink J. Andres R. Deans F. Barry S Bruder M. Thiede A. Moseley and J. Burns for discussion and review of the manuscript; M. Black and M. Earlington for cell isolation from marrow; and D. Sterchi D. Brown and J. Skwarek for histology. This work was supported by Osiris Therapeutics (www.osiristx.com) and in part by a research contract from the Defense Advanced Research Projects Agency.